Chromosome 4q25 Variant rs6817105 Bring Sinus Node Dysfunction and Left Atrial Enlargement

Area of Science:

• Genetics
• Cardiology
• Molecular Biology

Background:

• Genome-wide association studies identified a strong link between the rs6817105 SNP and atrial fibrillation (AF).
• Phenotypic consequences of the rs6817105 SNP, particularly in relation to AF, remain largely undescribed.
• MicroRNAs (miRNAs) are implicated in atrial remodeling and AF pathogenesis.

Purpose of the Study:

• To investigate the phenotypic alterations associated with the rs6817105 SNP in atrial fibrillation patients.
• To examine the relationship between rs6817105 genotype and clinical, echocardiographic, and electrophysiological parameters.
• To explore potential links between rs6817105 genotype and serum miRNA concentrations.

Main Methods:

• Genotyping of the rs6817105 SNP in 574 AF patients and 1,554 non-AF controls.
• Analysis of clinical characteristics, echocardiographic parameters (e.g., left atrial volume index), and electrophysiological parameters (e.g., corrected sinus node recovery time).
• Quantification of serum miRNA concentrations for 2555 miRNAs in relation to rs6817105 genotype.

Main Results:

• The minor allele frequency of rs6817105 was significantly higher in AF patients (66%) compared to controls (47%), with a strong association (odds ratio 2.12, p < 10^-26).
• AF patients carrying the minor allele of rs6817105 exhibited longer corrected sinus node recovery time (CSRT) (p=0.001) and larger left atrial volume index (LAVI) (p=0.030).
• No significant associations were found between rs6817105 genotype and serum miRNA concentrations.

Conclusions:

• The rs6817105 minor allele is strongly implicated in sinus node dysfunction.
• Left atrial enlargement is associated with the rs6817105 minor allele in the context of AF.
• The rs6817105 SNP influences AF pathophysiology through mechanisms potentially independent of circulating miRNA levels.